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ABSTRACT
A range of pesticides is widely used in pest management and the chances of exposure to multiple organophosphorus (OP) com-
pounds simultaneously are high, especially from dietary and other sources. Although health hazards of individual OP insecticides 
have been relatively well characterized, there is lesser information on the interactive toxicity of multiple OP insecticides. The aim of 
this study is to elicit the possible interactions in case combined exposure of an OP pesticide chlorpyrifos (CPF) and a plant growth 
regulator ethephon (ETF) which are used worldwide. The ileum segments of 3 months old Wistar Albino male rats were used in 
isolated organ bath containing Tyrode solution. ETF and CPF were incubated (10–7 M concentration) separately or in combination with 
each other to ileum and their effects on acetylcholine-induced contractions were studied. The data obtained from this study show 
that, single and combined exposure to the agents caused agonistic interactions with regard to potency of ACh whereas they caused 
a decrease on Emax value of ACh. These findings suggest that exposure to these agents which have direct and indirect cholinergic 
effects, may cause developing clinical responses with small doses and earlier but the extent of toxicity will be lower. 
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was tested the same way as an OP insecticide. It mark-
edly inhibited plasma butyrylcholinesterase (BChE) with 
much less effect on brain or erythrocyte AChE in rats and 
mice both in vitro and in vivo (Haux et al., 2002). 
Chlorpyrifos [O,O-diethyl O-(3,5,6-trichloro-2-
pyridinyl)-phosphorothioate] (CPF), is a broad-spectrum, 
chlorinated organophosphate insecticide (Smegal, 2000) 
known to cause acute toxicity through irreversible inhibi-
tion of AChE (Chanda et al., 1997) via one of its major 
metabolites, chlorpyrifos oxon (CPO) (Cook and Shenoy, 
2003). The parent OPs, like chlorpyrifos, are weak inhibi-
tors of AChE which must first undergo CYP-mediated 
oxidative desulfuration to CPO, to become an inhibitor of 
cholinesterase activity (Cochran, 2002; Poet et al., 2003; 
El-Masri et al., 2004). 
Oral absorption of a chemical or drug can be altered by 
both intestinal and liver metabolism. Although the blood 
flow and tissue volume of the intestine is slightly lower 
than the liver, the extensive microvilli structure results 
in a large surface area, ideally suited for absorption (Poet 
et al., 2003). The activation of CPF to CPO is mediated 
by cytochrome P450 mixed-function oxidases (CYP450), 
primarily within the liver. However, extrahepatic metabo-
lism has been reported in other tissues (Timchalk et al., 
Introduction
Organophosphorus (OP) pesticides are the major chemi-
cal class of insecticides used in the world today. The pri-
mary mode of action for OP pesticides is initiated through 
irreversible inhibition of acetylcholinesterase (AChE), the 
enzyme responsible for degrading the neurotransmitter 
acetylcholine (Howard and Pope, 2002; Kousba et al., 
2003).
Ethephon [(2-chloroethyl) phosphonic acid] (ETF) 
is a major plant growth regulator (PGR) that promotes 
fruit ripening, abscission, flower induction, and other 
responses by releasing ethylene gas, a natural plant 
hormone (Segall et al., 1991; EPA, 1995; Tomlin, 1997; 
Haux et al., 2000) which spontaneously decomposes at 
physiological pH (Zhang and Casida, 2002). ETF as an 
OP, even though it gives no cholinergic signs of poisoning, 
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2002). Enterocytes within the small intestine also possess 
CYP metabolic capacity, and in the case of some enzymes 
(i.e., 3A4) the concentration within the enterocytes is 
comparable to the liver (Poet et al., 2003). Intestinal 
CYP450 metabolism of drugs can be substantial, and is 
also likely to be an important contributor to CPF metabo-
lism (Timchalk et al., 2002). 
Acetylcholine is a well-recognized neurotransmitter 
in the gastrointestinal tract, and the activation of mus-
carinic cholinoceptors by acetylcholine is important in 
eliciting contraction of intestine and colon (Tezuka et al., 
2004). In small bowel, acetylcholine (ACh) released from 
intramural cholinergic nerves acts at nicotinic choliner-
gic receptors to cause excitation of enteric nerves and at 
muscarinic cholinergic receptors to cause contractions of 
intestinal smooth muscle (Taha et al., 2002).
Organophosphate (OP) pesticides are often used in 
combination with one another and with the components 
of formulations. Exposure to multiple OP-containing 
pesticide formulations may lead to synergistic neurotoxic-
ity by a direct mechanism at the cellular level (Axelrad et 
al., 2002). As a range of insecticides is extensively used in 
pest management, the chances of exposure to multiple OP 
compounds simultaneously are high, especially among 
agricultural and public health workers. Furthermore, 
from dietary and other sources, there may be separate but 
closely timed exposures to such insecticides. Although 
health hazards of individual OP insecticides have been 
relatively well characterized, there is lesser information 
on the interactive toxicity of multiple OP insecticides 
(Karanth et al., 2004).
The chance of exposing multiple pesticides from dif-
ferent sources, especially by ingestion of different kind 
of food, is very high, therefore the aim of current study 
is to investigate possible interactions of two different 
kind of widely used pesticides (a plant growth regulator 
ethephon and an insecticide chlorpyrifos) either alone or 
in combination, on ACh-induced contractions on rat ileal 
smooth muscle. 
Materials and methods
Animals and Tissue Preparation
Thr e e  m o n ths  o l d  m al e  W is tar  al b in o  r a ts  w e i ghin g  
150–180 g were used for the experiments. Rats were fasted 
overnight with free access to water. Prior to the begin-
ning of the experiments, rats were anesthetized by ether. 
Subsequently, the animals were sacrificed by cervical 
dislocation and small intestine was removed rapidly. The 
organ was transferred to a dish containing Tyrode solu-
tion. The study was approved by the Ethical Committee 
of University of Ankara, Faculty of Veterinary Medicine.
After the rinsing of the lumen and clearing of the 
adventitial tissue, longitudinal segments (10 mm long) 
were cut from ileum. The segment was tied at both ends 
with cotton-line, suspended under a load of 1  g in an 
organ bath containing 10 ml of Tyrode solution kept at 
37 °C and bubbled with a mixture of 95% O2 and 5% CO2 
(pH 7.4). The Tyrode solution had the following composi-
tion (mM): NaCl 136.9, KCl 2.68, CaCl2 1.8, MgCl2.6H2O 
1.05, NaH2PO4.2H2O 0.4, NaHCO3 11.9 and glucose 5.5. 
Mechanical activity of the segments, measured as changes 
in isometric tension, was recorded via an isometric force 
transducer (FDT-10A MAY) on a MAY Polygraph model 
TDA99 (MAY, Ankara, TURKEY). Each preparation was 
allowed to equilibrate for at least 60 min prior to initiat-
ing the experimental procedure. During the stabilization 
period the bath solution was changed every 15 minutes. 
The pD2 is defined as the negative logarithm of the 
EC50. The potency of a drug is commonly quantified as 
the EC50. It is the concentration of agonist required to 
provoke a response halfway between the baseline and 
maximum response (Emax) of a dose-response curve. 
The value of the highest contractile response (maximal 
contraction) was accepted as 100% and the percentages 
of the other contractile responses of the concentrations 
were calculated. With these calculations, pD2 and Emax 
values were obtained by using “GraphPad Prism ver.4 
for Windows”. Evaluation of the obtained responses was 
made by comparing the effects of agents on pD2 and Emax 
values of ACh.
Assays
Evaluating the effects of the agents on ACh induced contractions
The effects of agents on ACh were elicited by studying a 
control procedure. In the first stage, with this purpose, 
control ACh was applied cumulatively (10–9–10–4 M 
semi-logarithmically) to ileum tissue and corresponding 
concentration-response curve was obtained. From the 
curve, Emax and pD2 values and the mg values of high-
est contractile responses were calculated. In the second 
stage, this was followed by single or combined incubation 
of agents for 10 minutes before the addition of further 
c u m u l a t i v e  c o n c e n t r a t i o n s  o f  A C h .  T h u s ,  s i n g l e  a n d  
combined effects of agents on Emax and pD2 values of ACh 
were observed. Between two stages, incubation medium 
was changed three times in 45 minutes to restore the 
baseline.
Evaluating the single incubation of the agents
ACh was applied cumulatively to ileum tissue. After 
obtaining the control curve, the incubation medium was 
changed three times in 45 minutes to restore the baseline. 
This was followed by incubation of single agent (ETF or 
CPF) for 10 minutes with 10–7 M concentration before the 
addition of further cumulative concentrations of ACh. 
Evaluating the combined incubation of the agents
Control curve was obtained by applying ACh (10–9–10–4 M 
semi-logarithmically) cumulatively to ileum tissue. The 
incubation medium was changed three times. After 
restoring the base line, combined ETF (10–7 M) and CPF 
(10–7 M) were exposed to ileum tissue at the same time 
(the half of single exposure dose used for each agent) for 
10 minutes and then further cumulative concentrations 
of ACh was added. 37
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Evaluating cumulative exposure of agents on ileum tissue
The cumulative (10–10–10–6 M logarithmically) applica-
tion of agents (ETF or CPF) was also studied separately to 
obtain the corresponding concentration-response curve. 
The mg values of every contractile response were calcu-
lated. The highest contractile response was accepted 100% 
and according to this highest response, the percentages of 
responses of other contractions were also calculated. 
Chemicals
Acetylcholine chloride (CAS No: 60-31-1, Sigma A6625) 
was purchased from Sigma Chemical Company. Ethephon 
(CAS No: 16672-87-0) is freely soluble in water. EFHUN 
250 cc (480 g/l Ethephon), a commercial water-based 
product of ethephon was purchased from Agrobest 
Company (Ankara, TURKEY). All drugs were dissolved in 
distilled water. Chlorpyrifos (CAS No: 2921-88-2) was of 
analytical grade and purchased from Dow AgroSciences. 
Chlorpyrifos is practically insoluble in water, therefore, 
it was first dissolved in acetone (35 mg/10 ml) and then 
dilutions were made with distilled water.
Statistics and data analysis
Statistical calculations and graphs are made with 
“GraphPad Prism ver.4 for Windows”. The data are 
expressed as mean ± SE. Results are expressed as a per-
centage of the maximum contraction of the first acetyl-
choline curve. All results are expressed as mean ± SEM of 
six or more preparations obtained from different animals. 
Wilcoxon Signed Ranks Nonparametric tests were used to 
compare ACh control curve and ACh curve after incuba-
tion of agents. The concentration needed to produce 50% 
contraction effect (EC50) was obtained from the regres-
sion plot and mean EC50 ± 95% confidence intervals was 
calculated for each dose assessed and maximum values 
were obtained from each concentration-response curve 
(Emax). Differences were considered significant when 
p-value is <0.05.
Results
The eff  ects of incubation on ACh induced contractions
Ethephon
The changes on pD2 and Emax values of ACh on rat ileum 
after incubating (10 min) with Ethephon (10–7 M), are 
shown in Table 1. According to the obtained results, 
the pD2 value of ACh increased (ACh: 6.241 ± 0.165 and 
ETF incubation: 6.447  ±  0.160) and the Emax values of 
ACh decreased (ACh: 94.88  ±  2.34 and ETF incubation: 
82.60  ±  4.15). These changes are statistically significant 
(p<0.05). 
Chlorpyrifos
The changes on pD2 and Emax values of ACh on rat ileum 
after incubating (10 min) with Chlorpyrifos (10–7 M), are 
shown in Table 1. According to the results, the pD2 value 
of ACh increased (ACh: 6.210 ± 0.070 and CPF incubation: 
6.575 ± 0.236) and the Emax values of ACh decreased (ACh: 
94.58  ±  2.48 and CPF incubation: 86.26  ±  4.36). These 
changes are statistically significant (p<0.05). 
Combination
The changes on pD2 and Emax val u es  o f  A Ch  o n  ra t  
ileum after incubating (10 min) simultaneously with 
Ethephon(10–7 M) and Chlorpyrifos (10–7 M) are shown 
in Table 1. Results show that the pD2 value of ACh 
increased (ACh: 6.164 ± 0.065 and [ETF+CPF] incubation: 
6.247 ± 0.069) and the Emax values of ACh decreased (ACh: 
93.76  ±  1.52 and [ETF+CPF] incubation: 86.25  ±  3.67). 
These changes are statistically significant (p<0.05). 
The eff  ects of cumulative exposure of the agents on ileum
The average mg values of the highest contractions and the 
responses of cumulatively applied ETF (10–10–10–6 M) on 
ileum are shown in Figure 1 and Table 2 respectively. 
The average mg values of the highest contractions and 
the responses of cumulatively applied CPF (10–10–10–6 M) 
on ileum are shown in Figure 2 and Table 2 respectively. 
Table 1. Effects of agents either alone or in combination on pD2 and 
Emax values of ACh on rat ileum before and after incubation.
pD2 Emax 
ACh (n = 9) 6.241 ± 0.165 94.88 ± 2.34
ETF (10–7 M) incubation 6.447 ± 0.160* 82.60 ± 4.15*
ACh (n = 15) 6.210 ± 0.070 94.58 ± 2.48
CPF (10–7 M) incubation 6.575 ± 0.236* 86.26 ± 4.36*
   ACh  (n  =  19) 6.164 ± 0.065 93.76 ± 1.52
ETF+CPF (10–7 M) incubation 6.247 ± 0.069* 86.25 ± 3.67*
Data are reported as mean ± SE; * p<0.05 compared to control.
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Figure 1. The average mg values of the highest contractions and 
the responses of cumulatively applied ETF on ileum. 38
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It is seen that the cumulative (10–10–10–6 M) applica-
tion of ETF or CPF on rat ileum cause contractions which 
are not similar to specific graded concentration-response. 
These contractions have no graded increase related to 
concentrations, so appropriate Emax and pD2 values can 
not be calculated. Cumulative concentration-response of 
ACh (10–9–10–4 M, semi-logaritmically) that is appropri-
ate to specific graded concentration-response, is shown 
in Figure 3. 
Discussion
There is an increase of potency of ACh and a decrease 
of maximum effect of ACh on rat ileum after incubat-
ing both with ETF (10–7 M) and with CPF (10–7 M) 
(Table 1). These results show that the ACh concentration 
is increased in synaptic cleft by AChE inhibition because 
agents act as acetylcholinesterase inhibitors and also the 
contractions are decreased because agents bind directly 
to the receptors. The changes are statistically significant 
but also biologically important because toxicity and 
desensitisation by ETF or CPF occurs earlier with lower 
ACh concentrations. 
Similar studies which involve increase in potency of 
choline esters are available. According to Sparks et al. 
(1999), pretreatment of mice i.p. with ETF decreases the 
LD50 of succinylcholine in comparison with controls, that 
is, a toxicity increase of fourfold. Mice are sensitized to 
succinylcholine toxicity when their serum BuChE activity 
is inhibited 77–94% by ethephon with pretreatment time 
of 1 hour. 
The maximum effect of agents (Table 2) is lower than 
that of ACh, therefore after incubating with ETF (10–7 M) 
or CPF (10–7 M), occupation of receptors by ETF or CPF 
may cause a decrease in Emax value of ACh. The down-
regulation is likely responsible for this decrease. Cochran 
( 2 0 0 2 )  s t a t e d  t h a t  a d a p t i v e  r e s p o n s e s  t o  s i n g l e  a n d  
multiple doses of chlorpyrifos include down-regulation of 
acetylcholine receptors and reduced synthesis of acetyl-
choline, so that the presynaptic release of acetylcholine 
is restricted. 
The interaction of some cholinesterase inhibitors with 
cholinergic receptors is known for many years. A number 
of studies have evaluated effects of anticholinesterases on 
muscarinic receptor binding. Paraoxon, malaoxon and 
chlorpyrifos oxon inhibited [3H]cisdioxolane binding in 
a concentration dependent manner at sub-micromolar 
concentrations (potencies: chlorpyrifos oxon > paraoxon 
> malaoxon). Chlorpyrifos oxon, paraoxon and methyl 
paraoxon displaced [3H]oxotremorine-M binding to rat 
cardiac membrane muscarinic receptors with chlorpy-
rifos oxon being most potent (IC50 = 7 nM) (Pope et al., 
2005).
Similar to the responses of single exposures, combined 
exposure of ETF and CPF on rat ileum caused increase in 
pD2 values (p<0.05) and decrease in Emax values (p<0.05) 
of concentration-response curves of ACh (Table 1). 
A number of studies have compared the single and 
combined exposures. These studies indicate that combi-
nations may change potency of each other as agonistic or 
antagonistic manner. El-Masri et al. (2004) used the over-
all model to investigate the mechanism of interaction and 
to calculate interaction threshold doses at various dose 
levels of CPF and parathion which have to be metabo-
lized to their corresponding oxon forms to be effective. 
The overall model simulations indicated that additivity 
is obtained at oral lower dose levels of each chemical. 
At higher doses, antagonism by enzymatic competitive 
inhibition is the mode of interaction.
Pharmacokinetic and pharmacodynamic interaction 
for a binary mixture of chlorpyrifos and diazinon in the 
rat was examined in another study. It is reported that a 
dose-dependent inhibition of ChE was noted in tissues for 
both the single and coexposures and the overall relative 
potency for ChE inhibition was CPF/DZN > CPF > DZN 
(Timchalk et al., 2005).
The continuous and strong decrease in Emax value of 
ACh after incubating with ETF and/or CPF on rat ileum 
is possibly related to down-regulation of the number of 
receptors that ACh can be bound. Becerra et al. (2001) 
have examined the action of tacrine on muscarinic recep-
tors in rat intestinal smooth muscle. The results indicate 
that tacrine has a biphasic effect: an increase of the ACh 
concentration because of it acting as an anticholinesterasic 
agent and a decrease on the contraction by ACh because 
of muscarinic receptor blockade. As the cholinesterase 
Table 2. The average mg values of highest contractions of cumulatively 
applied ETF or CPF on rat ileum. 
Highest contraction 
(mg ± SEM) n
ETF (10–10–10–6 M) 413 ± 63 10
CPF (10–10–10–6 M) 461 ± 76 9
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Figure 2. The average mg values of the highest contractions and 
the responses of cumulatively applied CPF on ileum. 39
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inhibitors prolong the maintenance of ACh in the bath, 
desensitisation occurs earlier with lower ACh concentra-
tions. In addition, with these actions in vitro, long-term 
administration of cholinesterase inhibitors is known to 
result in a reduction in the number of muscarinic recep-
tors and tacrine selectively down-regulates the number 
but not the affinity of M1 receptors. The results of the 
study have similar points with our study and the decrease 
in Emax value of ACh can be explained by down-regulation 
with ETF and/or CPF. 
In conclusion, single and combined exposure to the 
agents used in this study caused agonistic interactions 
with regard to potency of ACh whereas they caused a 
decrease on Emax value of ACh. These findings suggest 
tha t exposur e to th ese ag e n ts whi ch ha v e dir ect an d  
indirect cholinergic effects, may cause developing clinical 
responses with small doses and earlier but the extent of 
toxicity will be lower.
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